Lisanti Capital Growth, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$7,025,312
+48.2%
78,425
+36.9%
1.11%
+67.9%
Q1 2023$4,739,506
-38.2%
57,275
-41.3%
0.66%
-36.9%
Q4 2022$7,669,948
+13.9%
97,520
+82.7%
1.05%
-52.3%
Q3 2019$6,734,000
+43.9%
53,385
+14.2%
2.20%
+16.2%
Q4 2018$4,679,000
+69.3%
46,765
+93.9%
1.89%
+96.9%
Q3 2018$2,764,00024,1200.96%
Other shareholders
HAEMONETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders